October 26, 2020
Virtual Events    Webinars      Whitepapers      OnDemand Learning     Podcasts

1. AstraZeneca, Johnson & Johnson COVID-19 vaccine trials to resume Full story

2. Remdesivir becomes first FDA-approved COVID-19 treatment Full story

3. Convalescent plasma shows no benefit for COVID-19 patients in clinical trial Full story

4. Join this virtual discussion to learn about how different care settings are improving medication adherence and how leaders are meeting challenges with new staffing approaches. 

5. Pharmacy techs will be allowed to administer COVID-19 vaccines, tests, HHS says Full story

6. Equitas Health, Prism Health North Texas open 2 new pharmacies Full story

7. Receiving the wrong drug can be dangerous, but so can receiving the wrong dose. Click here to learn how to properly adjust dosages for patients with kidney conditions. 

8. 4 takeaways from the FDA vaccine advisory panel meeting Full story

9. FDA flags quality issues with Eli Lilly plant that makes its COVID-19 antibody drug Full story

10. Indivior CEO gets 6 months in prison for Suboxone scheme Full story

11. Is your health system prepared to face 2021’s drug shortages? Click here to learn how data and AI can help manage hospitals’ drug supply needs. 

12. Daily COVID-19 stats, state-by-state:

Zero contact, zero wait times, zero delays: 3 reasons why now is the time to turn to a remote patient intake solution

Clean up the paper trail: How healthcare providers can streamline operations with digital documentation

What can your organization do to manage high-cost, innovative therapies now and in the future?

Companies to Know
Thank you to our key sponsors


Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

View our profile on LinkedIn Follow us on Twitter Like us on Facebook Check our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication